Abstract
46. Reijneveld JC, Koot RW, Bredman JJ et al. Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on the development of myopathy in young rats. Pediatr Res 1996; 39: 1028– 1035 47. Suzumura K, Tanaka K, Yasuhara M, Narita H. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein. Biol Pharm Bull 2000; 23: 873–878 48. Kurusu A, Shou I, Nakamura S et al. Effects of the new hydroxy-3methylglutaryl coenzyme a reductase inhibitor fluvastatin on antioxidant enzyme activities and renal function in streptozotocininduced diabetic rats. Clin Exp Pharmacol Physiol 2000; 27: 767– 770 49. Moriyama T, Kawada N, Nagatoya K et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 2001; 59: 2095– 2103 50. Gianella A, Nobili E, Abbate M et al. Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am J Pathol 2007; 170: 1165–1177
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
